Magnesium valproate sustained release tablets induced pancytopenia: a case report

Magnesium valproate has been shown to be clinically effective in the treatment of various types of epilepsy and is an FDA approved drug for bipolar disorder. Clinical reactions of valproate varied greatly among individuals. Digestive tract dysfunction and liver dysfunction were common adverse reactions of magnesium valproate sustained release tablets, while pancytopenia caused by valproate was rarely reported. This paper reported a case of pancytopenia induced by magnesium valproate sustained release tablet, which arouse widespread attention in clinical.